Dual-Action Molecule Design Concentrates Cancer Treatment in Tumor Cells to Allow Higher Doses
Newswise — PHILADELPHIA — (FEB, 6, 2026) — Wistar scientists have combined a promising cancer therapy with a…
The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research
Philadelphia-led consortium is selected to tailor HIV curative strategies to participant Philadelphia, PA, Aug. 19, 2025 (GLOBE NEWSWIRE)…